vs
Astrana Health, Inc.（ASTH）与Qorvo, Inc.（QRVO）财务数据对比。点击上方公司名可切换其他公司
Qorvo, Inc.的季度营收约是Astrana Health, Inc.的1.0倍（$993.0M vs $950.5M），Qorvo, Inc.净利率更高（16.5% vs 0.7%，领先15.8%），Astrana Health, Inc.同比增速更快（42.9% vs 8.4%），Qorvo, Inc.自由现金流更多（$236.9M vs $-6.0M），过去两年Astrana Health, Inc.的营收复合增速更高（53.3% vs 2.7%）
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
Qorvo是一家美国跨国企业，专注于无线、有线及电源市场相关产品的研发与供应。该公司由TriQuint半导体与RF Micro Devices合并而来，合并计划于2014年公布，2015年1月1日正式完成，在纳斯达克挂牌上市，股票代码QRVO，原实行双总部制，2016年中起将北卡罗来纳州基地作为总部所在地。
ASTH vs QRVO — 直观对比
营收规模更大
QRVO
是对方的1.0倍
$950.5M
营收增速更快
ASTH
高出34.5%
8.4%
净利率更高
QRVO
高出15.8%
0.7%
自由现金流更多
QRVO
多$242.9M
$-6.0M
两年增速更快
ASTH
近两年复合增速
2.7%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $950.5M | $993.0M |
| 净利润 | $6.6M | $164.1M |
| 毛利率 | — | 46.7% |
| 营业利润率 | 1.9% | 19.4% |
| 净利率 | 0.7% | 16.5% |
| 营收同比 | 42.9% | 8.4% |
| 净利润同比 | 184.4% | 297.5% |
| 每股收益（稀释后） | $0.12 | $1.75 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTHQRVO
| Q4 25 | $950.5M | $993.0M | ||
| Q3 25 | $956.0M | $1.1B | ||
| Q2 25 | $654.8M | $818.8M | ||
| Q1 25 | $620.4M | $869.5M | ||
| Q4 24 | $665.2M | $916.3M | ||
| Q3 24 | $478.7M | $1.0B | ||
| Q2 24 | $486.3M | $886.7M | ||
| Q1 24 | $404.4M | $941.0M |
净利润ASTHQRVO
| Q4 25 | $6.6M | $164.1M | ||
| Q3 25 | $373.0K | $119.6M | ||
| Q2 25 | $9.4M | $25.6M | ||
| Q1 25 | $6.7M | $31.4M | ||
| Q4 24 | $-7.8M | $41.3M | ||
| Q3 24 | $16.1M | $-17.4M | ||
| Q2 24 | $19.2M | $414.0K | ||
| Q1 24 | $14.8M | $2.7M |
毛利率ASTHQRVO
| Q4 25 | — | 46.7% | ||
| Q3 25 | — | 47.0% | ||
| Q2 25 | — | 40.5% | ||
| Q1 25 | — | 42.2% | ||
| Q4 24 | — | 42.7% | ||
| Q3 24 | — | 42.6% | ||
| Q2 24 | — | 37.5% | ||
| Q1 24 | — | 40.6% |
营业利润率ASTHQRVO
| Q4 25 | 1.9% | 19.4% | ||
| Q3 25 | 2.0% | 14.9% | ||
| Q2 25 | 3.1% | 3.7% | ||
| Q1 25 | 3.3% | 3.2% | ||
| Q4 24 | 0.1% | 5.8% | ||
| Q3 24 | 5.9% | 0.9% | ||
| Q2 24 | 6.2% | 0.5% | ||
| Q1 24 | 7.5% | 3.2% |
净利率ASTHQRVO
| Q4 25 | 0.7% | 16.5% | ||
| Q3 25 | 0.0% | 11.3% | ||
| Q2 25 | 1.4% | 3.1% | ||
| Q1 25 | 1.1% | 3.6% | ||
| Q4 24 | -1.2% | 4.5% | ||
| Q3 24 | 3.4% | -1.7% | ||
| Q2 24 | 3.9% | 0.0% | ||
| Q1 24 | 3.7% | 0.3% |
每股收益（稀释后）ASTHQRVO
| Q4 25 | $0.12 | $1.75 | ||
| Q3 25 | $0.01 | $1.28 | ||
| Q2 25 | $0.19 | $0.27 | ||
| Q1 25 | $0.14 | $0.33 | ||
| Q4 24 | $-0.14 | $0.43 | ||
| Q3 24 | $0.33 | $-0.18 | ||
| Q2 24 | $0.40 | $0.00 | ||
| Q1 24 | $0.31 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $1.3B |
| 总债务越低越好 | — | $1.5B |
| 股东权益账面价值 | $779.3M | $3.7B |
| 总资产 | $2.2B | $6.2B |
| 负债/权益比越低杠杆越低 | — | 0.42× |
8季度趋势，按日历期对齐
现金及短期投资ASTHQRVO
| Q4 25 | $429.5M | $1.3B | ||
| Q3 25 | $463.4M | $1.1B | ||
| Q2 25 | $342.1M | $1.2B | ||
| Q1 25 | $260.9M | $1.0B | ||
| Q4 24 | $290.8M | $769.4M | ||
| Q3 24 | $350.3M | $1.1B | ||
| Q2 24 | $327.7M | $1.1B | ||
| Q1 24 | $337.3M | $1.0B |
总债务ASTHQRVO
| Q4 25 | — | $1.5B | ||
| Q3 25 | — | $1.5B | ||
| Q2 25 | — | $1.5B | ||
| Q1 25 | — | $1.5B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | — | $1.5B | ||
| Q2 24 | — | $1.5B | ||
| Q1 24 | — | $1.5B |
股东权益ASTHQRVO
| Q4 25 | $779.3M | $3.7B | ||
| Q3 25 | $775.5M | $3.5B | ||
| Q2 25 | $765.5M | $3.4B | ||
| Q1 25 | $745.4M | $3.4B | ||
| Q4 24 | $712.7M | $3.4B | ||
| Q3 24 | $704.6M | $3.4B | ||
| Q2 24 | $678.9M | $3.5B | ||
| Q1 24 | $653.5M | $3.6B |
总资产ASTHQRVO
| Q4 25 | $2.2B | $6.2B | ||
| Q3 25 | $2.2B | $6.1B | ||
| Q2 25 | $1.4B | $6.0B | ||
| Q1 25 | $1.3B | $5.9B | ||
| Q4 24 | $1.4B | $6.0B | ||
| Q3 24 | $1.3B | $6.5B | ||
| Q2 24 | $1.3B | $6.4B | ||
| Q1 24 | $1.2B | $6.6B |
负债/权益比ASTHQRVO
| Q4 25 | — | 0.42× | ||
| Q3 25 | — | 0.44× | ||
| Q2 25 | — | 0.45× | ||
| Q1 25 | — | 0.46× | ||
| Q4 24 | — | 0.46× | ||
| Q3 24 | — | 0.45× | ||
| Q2 24 | — | 0.44× | ||
| Q1 24 | — | 0.44× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $265.4M |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | $236.9M |
| 自由现金流率自由现金流/营收 | -0.6% | 23.9% |
| 资本支出强度资本支出/营收 | 0.3% | 2.9% |
| 现金转化率经营现金流/净利润 | -0.44× | 1.62× |
| 过去12个月自由现金流最近4个季度 | $104.5M | $595.2M |
8季度趋势，按日历期对齐
经营现金流ASTHQRVO
| Q4 25 | $-2.9M | $265.4M | ||
| Q3 25 | $10.0M | $84.0M | ||
| Q2 25 | $90.9M | $182.9M | ||
| Q1 25 | $16.6M | $199.2M | ||
| Q4 24 | $-10.9M | $214.1M | ||
| Q3 24 | $34.0M | $127.8M | ||
| Q2 24 | $23.2M | $81.1M | ||
| Q1 24 | $6.0M | — |
自由现金流ASTHQRVO
| Q4 25 | $-6.0M | $236.9M | ||
| Q3 25 | $7.4M | $42.2M | ||
| Q2 25 | $89.5M | $145.4M | ||
| Q1 25 | $13.6M | $170.7M | ||
| Q4 24 | $-13.5M | $176.2M | ||
| Q3 24 | $31.7M | $94.8M | ||
| Q2 24 | $20.4M | $42.9M | ||
| Q1 24 | $5.6M | — |
自由现金流率ASTHQRVO
| Q4 25 | -0.6% | 23.9% | ||
| Q3 25 | 0.8% | 4.0% | ||
| Q2 25 | 13.7% | 17.8% | ||
| Q1 25 | 2.2% | 19.6% | ||
| Q4 24 | -2.0% | 19.2% | ||
| Q3 24 | 6.6% | 9.1% | ||
| Q2 24 | 4.2% | 4.8% | ||
| Q1 24 | 1.4% | — |
资本支出强度ASTHQRVO
| Q4 25 | 0.3% | 2.9% | ||
| Q3 25 | 0.3% | 3.9% | ||
| Q2 25 | 0.2% | 4.6% | ||
| Q1 25 | 0.5% | 3.3% | ||
| Q4 24 | 0.4% | 4.1% | ||
| Q3 24 | 0.5% | 3.2% | ||
| Q2 24 | 0.6% | 4.3% | ||
| Q1 24 | 0.1% | — |
现金转化率ASTHQRVO
| Q4 25 | -0.44× | 1.62× | ||
| Q3 25 | 26.69× | 0.70× | ||
| Q2 25 | 9.65× | 7.15× | ||
| Q1 25 | 2.48× | 6.35× | ||
| Q4 24 | — | 5.19× | ||
| Q3 24 | 2.11× | — | ||
| Q2 24 | 1.21× | 195.86× | ||
| Q1 24 | 0.40× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
QRVO
| ACG | $690.8M | 70% |
| HPA | $190.9M | 19% |
| CSG | $111.3M | 11% |
